290 related articles for article (PubMed ID: 17609120)
1. Inverse agonist-induced signaling and down-regulation of the platelet-activating factor receptor.
Dupré DJ; Thompson C; Chen Z; Rollin S; Larrivée JF; Le Gouill C; Rola-Pleszczynski M; Stanková J
Cell Signal; 2007 Oct; 19(10):2068-79. PubMed ID: 17609120
[TBL] [Abstract][Full Text] [Related]
2. Trafficking, ubiquitination, and down-regulation of the human platelet-activating factor receptor.
Dupré DJ; Chen Z; Le Gouill C; Thériault C; Parent JL; Rola-Pleszczynski M; Stankova J
J Biol Chem; 2003 Nov; 278(48):48228-35. PubMed ID: 14500726
[TBL] [Abstract][Full Text] [Related]
3. Inverse agonist activity of selected ligands of platelet-activating factor receptor.
Dupré DJ; Le Gouill C; Rola-Pleszczynski M; Stanková J
J Pharmacol Exp Ther; 2001 Oct; 299(1):358-65. PubMed ID: 11561099
[TBL] [Abstract][Full Text] [Related]
4. Mechanism and regulation of neutrophil priming by platelet-activating factor.
Gay JC
J Cell Physiol; 1993 Jul; 156(1):189-97. PubMed ID: 8391006
[TBL] [Abstract][Full Text] [Related]
5. Platelet activating factor-induced neuronal apoptosis is initiated independently of its G-protein coupled PAF receptor and is inhibited by the benzoate orsellinic acid.
Ryan SD; Harris CS; Mo F; Lee H; Hou ST; Bazan NG; Haddad PS; Arnason JT; Bennett SA
J Neurochem; 2007 Oct; 103(1):88-97. PubMed ID: 17877634
[TBL] [Abstract][Full Text] [Related]
6. Mass-dependent signaling between G protein coupled receptors.
Huang JS; Dong L; Le Breton GC
Cell Signal; 2006 Apr; 18(4):564-76. PubMed ID: 16125366
[TBL] [Abstract][Full Text] [Related]
7. Synergistic effects of combined platelet-activating factor receptor and epidermal growth factor receptor targeting in ovarian cancer cells.
Yu Y; Zhang M; Zhang X; Cai Q; Hong S; Jiang W; Xu C
J Hematol Oncol; 2014 May; 7():39. PubMed ID: 24886678
[TBL] [Abstract][Full Text] [Related]
8. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
Chen J; Giri SN
J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
[TBL] [Abstract][Full Text] [Related]
9. Human mesenchymal stem cells in the tumour microenvironment promote ovarian cancer progression: the role of platelet-activating factor.
Gao T; Yu Y; Cong Q; Wang Y; Sun M; Yao L; Xu C; Jiang W
BMC Cancer; 2018 Oct; 18(1):999. PubMed ID: 30340558
[TBL] [Abstract][Full Text] [Related]
10. Expression of the platelet-activating factor receptor enhances benzyl isothiocyanate-induced apoptosis in murine and human melanoma cells.
Sahu RP
Mol Med Rep; 2015 Jul; 12(1):394-400. PubMed ID: 25695262
[TBL] [Abstract][Full Text] [Related]
11. Platelet-activating factor induction of secreted phosphatase activity in Trypanosoma cruzi.
Rodrigues CO; Dutra PM; Barros FS; Souto-Padrón T; Meyer-Fernandes JR; Lopes AH
Biochem Biophys Res Commun; 1999 Dec; 266(1):36-42. PubMed ID: 10581161
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of platelet-activating factor receptors in lung and alveolar macrophages in the bleomycin-hamster model of pulmonary fibrosis.
Chen J; Ziboh V; Giri SN
J Pharmacol Exp Ther; 1997 Mar; 280(3):1219-27. PubMed ID: 9067307
[TBL] [Abstract][Full Text] [Related]
13. Functional platelet-activating factor receptors are expressed by monocytes and granulocytes but not by resting or activated T and B lymphocytes from normal individuals or patients with asthma.
Simon HU; Tsao PW; Siminovitch KA; Mills GB; Blaser K
J Immunol; 1994 Jul; 153(1):364-77. PubMed ID: 8207248
[TBL] [Abstract][Full Text] [Related]
14. Opposite effects of WEB2086 on angiogenesis in atheromas and ischemic hindlimb of apoE gene deficient mice.
Wang S; Tang YL; Yang YZ; Xu ZX; Peng K
Chin Med J (Engl); 2007 May; 120(10):886-92. PubMed ID: 17543178
[TBL] [Abstract][Full Text] [Related]
15. Albuterol isomers modulate platelet-activating factor synthesis and receptor signaling in human bronchial smooth muscle cells.
Bae R; Arteaga A; Raj JU; Ibe BO
Int Arch Allergy Immunol; 2012; 158(1):18-26. PubMed ID: 22212397
[TBL] [Abstract][Full Text] [Related]
16. Novel effect of Y-24180, a presumed specific platelet activation factor receptor antagonist, on Ca2+ levels and growth of human prostate cancer cells.
Jan CR; Chao YY
Cell Signal; 2004 Aug; 16(8):959-65. PubMed ID: 15157675
[TBL] [Abstract][Full Text] [Related]
17. Activation via multiple signaling pathways induces down-regulation of platelet-activating factor receptors on human B lymphocytes.
Zhuang Q; Bastien Y; Mazer BD
J Immunol; 2000 Sep; 165(5):2423-31. PubMed ID: 10946267
[TBL] [Abstract][Full Text] [Related]
18. Ubiquitin/proteasome-dependent down-regulation following clathrin-mediated internalization of histamine H1-receptors in Chinese hamster ovary cells.
Hishinuma S; Komazaki H; Fukui H; Shoji M
J Neurochem; 2010 May; 113(4):990-1001. PubMed ID: 20236220
[TBL] [Abstract][Full Text] [Related]
19. Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor.
Bennett SA; Birnboim HC
Mol Carcinog; 1997 Dec; 20(4):366-75. PubMed ID: 9433481
[TBL] [Abstract][Full Text] [Related]
20. Platelet-activating factor (PAF) positively auto-regulates the expression of human PAF receptor transcript 1 (leukocyte-type) through NF-kappa B.
Mutoh H; Ishii S; Izumi T; Kato S; Shimizu T
Biochem Biophys Res Commun; 1994 Dec; 205(2):1137-42. PubMed ID: 7802642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
